TREA

85262092 - PALVATA

Follow

Information

  • Trademark
  • 85262092
  • Serial Number
    85262092
  • Registration Number
    4647300
  • Filing Date
    March 09, 2011
    13 years ago
  • Registration Date
    December 02, 2014
    10 years ago
  • Transaction Date
    August 17, 2021
    3 years ago
  • Status Date
    July 09, 2021
    3 years ago
  • Published for Opposition Date
    September 16, 2014
    10 years ago
  • Location Date
    December 02, 2014
    10 years ago
Information
Mark Drawing Code
4000
Mark Identification
PALVATA
Case File Statements
  • GS0051: Pharmaceutical preparations, namely, pharmaceutical preparations and substances for the treatment of skin disorders, diseases, conditions and ailments; pharmaceutical preparations and products for use in dermatology; antifungal preparations; pharmaceutical preparations and substances for the treatment of eye disorders, diseases, conditions and ailments; pharmaceutical preparations and products for ophthalmological use; pharmaceutical preparations and substances for the treatment of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety, depression, depressive disorders and mental illness; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardiovascular system; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations and substances for use in chemotherapy; Pharmaceutical preparations and substances for use in urology; pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, anti-inflammatories and pain relief medication; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances for the treatment of fungal infections, onychomycosis, tinea infections, and similar diseases of the skin and nails; pharmaceutical preparations and substances for use in dermatological conditions
Case File Event Statements
  • 7/9/2021 - 3 years ago
    57 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 12/2/2019 - 5 years ago
    56 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 7/10/2019 - 5 years ago
    55 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 3/20/2019 - 5 years ago
    54 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/16/2018 - 6 years ago
    53 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/16/2018 - 6 years ago
    52 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/21/2018 - 6 years ago
    51 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 1/11/2017 - 7 years ago
    50 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 3/3/2016 - 8 years ago
    49 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/21/2015 - 9 years ago
    48 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 12/2/2014 - 10 years ago
    47 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/16/2014 - 10 years ago
    46 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/27/2014 - 10 years ago
    45 - NOTICE OF PUBLICATION Type: NPUB
  • 8/8/2014 - 10 years ago
    44 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/4/2014 - 10 years ago
    43 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/20/2014 - 10 years ago
    42 - FINAL REFUSAL MAILED Type: CNFR
  • 2/19/2014 - 10 years ago
    41 - FINAL REFUSAL WRITTEN Type: CNFR
  • 1/30/2014 - 10 years ago
    40 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/29/2014 - 10 years ago
    39 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/29/2014 - 10 years ago
    38 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/22/2014 - 10 years ago
    37 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/22/2014 - 10 years ago
    36 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 7/31/2013 - 11 years ago
    35 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/31/2013 - 11 years ago
    34 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/31/2013 - 11 years ago
    33 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/11/2013 - 11 years ago
    32 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/11/2013 - 11 years ago
    31 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/11/2013 - 11 years ago
    30 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/16/2013 - 11 years ago
    29 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 1/16/2013 - 11 years ago
    28 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/16/2013 - 11 years ago
    27 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/7/2013 - 11 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/7/2013 - 11 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/7/2013 - 11 years ago
    24 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 8/1/2012 - 12 years ago
    23 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 7/6/2012 - 12 years ago
    22 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 7/6/2012 - 12 years ago
    21 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 7/6/2012 - 12 years ago
    20 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 7/3/2012 - 12 years ago
    19 - LIE CHECKED SUSP - TO ATTY FOR ACTION Type: RCCK
  • 6/27/2012 - 12 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/26/2012 - 12 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/26/2012 - 12 years ago
    16 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 6/27/2012 - 12 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 12/15/2011 - 13 years ago
    14 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/15/2011 - 13 years ago
    13 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/15/2011 - 13 years ago
    12 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/15/2011 - 13 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/15/2011 - 13 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/15/2011 - 13 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 12/9/2011 - 13 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/9/2011 - 13 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/9/2011 - 13 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/9/2011 - 13 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/9/2011 - 13 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/6/2011 - 13 years ago
    3 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 3/14/2011 - 13 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 3/12/2011 - 13 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP